Racial Disparities in Cancer Guideline-Concordant Treatment Using Surveillance, Epidemiology, and End Results Data for Patients With NSCLC
Receiving GCIT considerably improves survival across all races, though disparities in receipt are observed. Interventions are needed to ensure equitable access to guideline-concordant care and reduce survival disparities for patients.
Authors
- Jacklyn Engelbart (ORCID: https://orcid.org/0000-0001-6650-7208)
- Thomas L. Casavant (ORCID: https://orcid.org/0000-0002-8051-4153)
- Jason Semprini (ORCID: https://orcid.org/0000-0002-0375-8090)
- Mary E. Charlton (ORCID: https://orcid.org/0000-0003-2409-1018)
- John M. Buatti (ORCID: https://orcid.org/0000-0001-8499-3721)
- Guadalupe Canahuate (ORCID: https://orcid.org/0000-0001-5873-5454)
- Amanda R. Kahl (ORCID: https://orcid.org/0000-0003-0041-1654)
- Cameron Trentz
- Eric Ababio Anyimadu (ORCID: https://orcid.org/0009-0004-3442-2401)
Institutions
- University of Iowa (US)
- University of Iowa Hospitals and Clinics (US)
- Des Moines University (US)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1016/j.jtocrr.2024.100747
- Citations
- 1
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- University of Iowa
- National Institutes of Health
- National Cancer Institute
- National Institute on Deafness and Other Communication Disorders